The Society for Immunotherapy of Cancer (SITC) and the World Immunotherapy Council (WIC), has invited general secretary Dr. Jyoti Bajpai and recognised the Immunooncology Society of India (I-OSI) as collaborative planning partner in the SITC 2019 World Immunotherapy Council’s 3rd Young Investigator Symposium on Wednesday, November 6, 2019 in National Harbour, MD, USA.

This symposium will provide the opportunity for young scientists and future leaders from throughout the world to interact, fulfilling the World Immunotherapy Council’s mission to facilitate rapid development and global dissemination of cancer immunotherapies through scientific exchange. The young investigators, each chosen for exemplary work in the field of cancer immunotherapy, will contribute insight and perspectives into present and future issues, challenges, and improvements as cancer immunotherapy is integrated into mainstream cancer treatment. This program and its participants will ultimately highlight worldwide initiatives in cancer immunotherapy and facilitate scientific exchange and networking between today’s and tomorrow’s leaders. Additionally, this forum will provide a unique opportunity to showcase the world’s young, talented scientists and provide an opportunity for knowledge exchange and networking for these selected representatives.

News And Updates

Immunotherapy is having potential to cure or provide long-term control against cancer

#Cancerimmunotherapy or #Immunooncology is an upcoming #advancetreatment with the potential to cure or provide long term control over cancer. Many cancer world over including India are getting approved or are approved for treatment with #cancerimmunotherapy. The article below is a humble effort to update Citizens on its potential. #ISOI......Read More

The fight within

The first time, it didn't seem so bad. Joaquin Fernandes's right leg had had a small blister, and like anyone else, he dismissed it as a corn, something that would disappear on its own. In the next few days, though, Fernandes noticed that the blister had begun to turn blackish and decided to see a doctor. Doctors in his city—the Goa-born civil engineer has been working with a construction company in Dubai for three decades now—advised biopsy...... Read More

Aung Naing

This is an important contribution as it reports on an often excluded patient population with critical unmet clinical needs.......Read More

JIPO Editors

Meet our new issue's guest editor, @HajjarJoud: Assistant Professor, Service Chief of Adult Allergy and Immunology, Section of Immunology, Allergy, and Rheumatology, Baylor College of Medicine and Texas Children Hospital, Houston, TX. Read the issue now: Read More